Keybanc Maintains Overweight on American Healthcares, Raises Price Target to $27
Portfolio Pulse from Benzinga Newsdesk
Keybanc analyst Austin Wurschmidt has maintained an Overweight rating on American Healthcares (NYSE:AHR) and raised the price target from $16 to $27.
September 16, 2024 | 12:44 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Keybanc has increased its price target for American Healthcares from $16 to $27, maintaining an Overweight rating. This suggests a positive outlook for the stock.
The increase in price target from $16 to $27 by Keybanc, along with maintaining an Overweight rating, indicates a strong positive sentiment from the analyst. This is likely to boost investor confidence and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100